Trials / Conditions / Malignant Ovarian Epithelial Tumor
Malignant Ovarian Epithelial Tumor
5 registered clinical trials studyying Malignant Ovarian Epithelial Tumor — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer NCT04055649 | Ira Winer | Phase 2 |
| Completed | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance NCT02020707 | Mayo Clinic | Phase 1 |
| Completed | Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone NCT01080521 | Gynecologic Oncology Group | — |
| Completed | Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary NCT00748657 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442 | Gynecologic Oncology Group | — |